Osmotica Pharmaceuticals plc Reports Second Quarter 2020 Results and Provides Business Updates
Second quarter 2020 total revenue of $37.5 millionReceived U.S Food and Drug Administration (“FDA”) approval for Upneeq™ (oxymetazoline hydrochloride ophthalmic […]